Cargando…

Veverimer: an advance in base therapy for metabolic acidosis

Detalles Bibliográficos
Autores principales: Brady, Clayton, Chemaly, Elie R., Lohr, James W., Parker, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661860/
https://www.ncbi.nlm.nih.gov/pubmed/33209911
http://dx.doi.org/10.21037/atm-20-2827
_version_ 1783609283437395968
author Brady, Clayton
Chemaly, Elie R.
Lohr, James W.
Parker, Mark D.
author_facet Brady, Clayton
Chemaly, Elie R.
Lohr, James W.
Parker, Mark D.
author_sort Brady, Clayton
collection PubMed
description
format Online
Article
Text
id pubmed-7661860
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-76618602020-11-17 Veverimer: an advance in base therapy for metabolic acidosis Brady, Clayton Chemaly, Elie R. Lohr, James W. Parker, Mark D. Ann Transl Med Editorial Commentary AME Publishing Company 2020-10 /pmc/articles/PMC7661860/ /pubmed/33209911 http://dx.doi.org/10.21037/atm-20-2827 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Brady, Clayton
Chemaly, Elie R.
Lohr, James W.
Parker, Mark D.
Veverimer: an advance in base therapy for metabolic acidosis
title Veverimer: an advance in base therapy for metabolic acidosis
title_full Veverimer: an advance in base therapy for metabolic acidosis
title_fullStr Veverimer: an advance in base therapy for metabolic acidosis
title_full_unstemmed Veverimer: an advance in base therapy for metabolic acidosis
title_short Veverimer: an advance in base therapy for metabolic acidosis
title_sort veverimer: an advance in base therapy for metabolic acidosis
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661860/
https://www.ncbi.nlm.nih.gov/pubmed/33209911
http://dx.doi.org/10.21037/atm-20-2827
work_keys_str_mv AT bradyclayton veverimeranadvanceinbasetherapyformetabolicacidosis
AT chemalyelier veverimeranadvanceinbasetherapyformetabolicacidosis
AT lohrjamesw veverimeranadvanceinbasetherapyformetabolicacidosis
AT parkermarkd veverimeranadvanceinbasetherapyformetabolicacidosis